How often ‘value-based care’ is uttered on Wall Street

This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox every Monday. Sign up here.

The explosion of ‘value-based care’ on Wall Street

“Value-based care” — that familiar, vague phrase that has no real definition but that everyone supports — is firmly entrenched in Wall Street vernacular.

The phrase “value-based care” began circulating during company earnings calls and presentations, and at banking conferences, in the second quarter of 2011, a year after former President Obama signed the Affordable Care Act into law, according to financial search engine and database AlphaSense. It’s been mentioned more than 1,800 times since then, peaking in 2022.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Hydrofarm Q2 Revenue Increases 1% From Q1

Hydrofarm Holdings Group Announces Second Quarter 2023 Results Shoemakersville, PA — August 9, 2023 — Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM),

August 10, 2023

Exclusive: A longtime VC takes on his own rare disease as Sanofi, Boehringer commit $80M to launch new platform study

Over three decades of investing, Luke Evnin has backed and advised dozens of biotechs developing medicines. Now, the longtime VC is turning his know-how and

December 19, 2023

Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer

The FDA approved lazertinib (Lazcluze) in combination with amivantamab (Rybrevant) for the first-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with

August 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.